The advantage of MCED testing is its potential to identify cancers at earlier, more treatable stages; detecting cancer even ...

An advocate is not the same as a health care proxy who is assigned to speak for a patient on their advanced directives.

She noted that she became a better nurse under his mentorship, thanks to the “wisdom and skills he instilled in [her].” His ...

The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...

Data from the COMMIT trial demonstrated that the addition of oxaliplatin, leucovorin, 5-fluorouracil (mFOLFOX6) and bevacizumab (Avastin) to atezolizumab (Tecentriq) significantly improves progression ...

Recent clinical developments in the treatment of platinum-resistant ovarian cancer (PROC) have introduced several novel therapeutic classes, including selective glucocorticoid receptor antagonists, ...

“Oncology nurses are unique in that we see patients for a long time. We get to know their families. We see them through graduation, through weddings, progression of disease, recurrence,” said ...

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

John Novak, PA-C | Authors | Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

The FDA approved a larger vial size of nelarabine for the treatment of pediatric and adult patients with T-ALL and T-LBL. The FDA approved a larger vial size of 375 mg/75 mL for nelarabine (Arranon) ...

Although steps have been taken to improve patient safety, patient identification errors can go undetected. In 2002, the Joint Commission created its National Patient Safety Goals program, which was ...

In 2021, immune checkpoint inhibitors were used by 12.1% of patients with cancer—however, these agents represent 36.2% of all oncology medication costs. Although novel immunotherapies hold promise for ...